FOXD2-AS1 was found to be highly expressed in colorectal cancer and nasopharyngeal carcinoma via regulation of miR-185-5p or miR-363-5p, which is associated with the promotion of cell proliferation or poor prognosis in patients [20,27]. This evidence concerns the gene FOXD2 and colorectal cancer.